Startups
Eurofarma
Edit

Eurofarma

https://eurofarma.com/
Last activity: 29.04.2024
Active
Categories: AdTechFamilyHealthTechIndustryITLifeManufacturingMedTechProductService
Since its establishment in 1972, Eurofarma has been operating in the health industry, producing and marketing products and services to improve people's quality of life. Focused on generating shared value, it operates in the areas of Prescription, Nos-Prescription, Generics, Hospital and Oncology. It offers over 700 products, over 2,000 SKUs and serves 42 medical specialties. In Brazil, it covers 100 therapeutic classes, which represent 70% of prescriptions in the entire market.

Operating in 20 countries, with manufacturing facilities in Brazil and industrial parks in six other Latin American countries, it generated net sales of R$ 7.1 billion in 2021, a growth of 23% compared to the previous year, and employs more than 8,100 people.
Likes
145.9K
Followers
719
Followers
844.18K
Mentions
2

Overview

Location
Brazil
Employees
5001-10000
Phone
0800 704 3876
Founded date
1972

Mentions in press and media 2

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Mar 21, 2024Henlius 2023 Annual Results: Revenue surpassed RMB5.39 billion with a net profit RMB546 million, first full-year profitability achievedSHANGHAI, March 21, 2024 /PRNewswire/ -- Henlius (2696.HK) announced its 2023 annual results. During the reporting period, Henlius' revenue reached about RMB5.3949 billion, representing an increase of 67.8% YoY, and recorded a net profit of...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Eurofarma

When was Eurofarma founded?

Eurofarma was founded in 1972.

What has the press written about Eurofarma?

Parsers VC has collected 2 articles mentioning Eurofarma, among them “Henlius 2023 Annual Results: Revenue surpassed RMB5.39 billion with a net profit RMB546 million, first full-year profitability achieved” (Mar 21, 2024).

Is Eurofarma still active?

Yes, Eurofarma is active; its latest activity on Parsers VC dates from Apr 29, 2024.